Sky Oak Wealth, LLC Neurocrine Biosciences Inc Transaction History

Sky Oak Wealth, LLC

  • $494 Million
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 03, 2020
SELL
$96.16 - $135.15 $192,320 - $270,300
-2,000 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$85.09 - $130.36 $170,180 - $260,720
2,000 New
2,000 $244,000
Q1 2020

May 04, 2020
SELL
$75.11 - $113.76 $183,869 - $278,484
-2,448 Closed
0 $0
Q4 2019

Feb 04, 2020
BUY
$86.8 - $118.57 $212,486 - $290,259
2,448 New
2,448 $263,000

Others Institutions Holding NBIX

# of Institutions
657
Shares Held
101M
Call Options Held
290K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sky Oak Wealth, LLC Portfolio

Follow Sky Oak Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Oak Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email